Femasys (FEMY) Depreciation & Amortization (CF) (2020 - 2026)
Femasys (FEMY) reported Depreciation & Amortization (CF) of $65578.0 for Q1 2026, down 15.58% on a YoY basis from $77682.0 in Q1 2025, and down 4.25% quarter-over-quarter from $68488.0 in Q4 2025.
Femasys (FEMY) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Femasys has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $65578.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 15.58% year-over-year to $65578.0; the trailing twelve-month figure through Mar 2026 stood at $283755.0 (changed 0.39% YoY), and the FY2025 full-year result was $295859.0, up 6.74% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $65578.0, down from $68488.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $136769.0 in Q1 2022, with the low at $63045.0 in Q2 2024.
- Historically, Depreciation & Amortization (CF) has averaged $97543.3 across 5 years, with a median of $77682.0 in 2025.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) plunged 52.38% — and 2025, when it climbed 23.19%.
- Femasys' Depreciation & Amortization (CF) stood at $132288.0 in 2022, then tumbled by 30.9% to $91410.0 in 2023, then fell by 18.82% to $74207.0 in 2024, then declined by 7.71% to $68488.0 in 2025, then decreased by 4.25% to $65578.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $65578.0 (Q1 2026), $68488.0 (Q4 2025), and $72022.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 151.46 Bn | 147.07 Bn | 1.83 Bn | 178.90 Mn |
| 2 | Becton Dickinson | 43.06 Bn | 42.04 Bn | 2.15 Bn | 563.00 Mn |
| 3 | Medline | 29.49 Bn | 35.33 Bn | 1.84 Bn | 254.00 Mn |
| 4 | Resmed | 28.58 Bn | 26.92 Bn | 890.98 Mn | 58.98 Mn |
| 5 | West Pharmaceutical Services | 24.11 Bn | 23.59 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 14.37 Bn | 14.37 Bn | 1.10 Bn | 135.00 Mn |
| 7 | Cooper Companies | 13.38 Bn | 13.25 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Align Technology | 12.72 Bn | 11.66 Bn | 736.59 Mn | 56.55 Mn |
| 9 | Baxter International | 10.32 Bn | 8.27 Bn | 891.00 Mn | 237.00 Mn |
| 10 | Femasys | 349.22 Mn | 343.84 Mn | - | 65,578.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,578.00 |
| Mar 31, 2026 | 65,578.00 |
| Dec 31, 2025 | 68,488.00 |
| Dec 31, 2025 | 68,488.00 |
| Sep 30, 2025 | 72,022.00 |
| Sep 30, 2025 | 72,022.00 |
| Jun 30, 2025 | 77,667.00 |
| Jun 30, 2025 | 77,667.00 |
| Mar 31, 2025 | 77,682.00 |
| Mar 31, 2025 | 77,682.00 |
| Dec 31, 2024 | 74,207.00 |
| Dec 31, 2024 | 74,207.00 |
| Sep 30, 2024 | 69,943.00 |
| Sep 30, 2024 | 69,943.00 |
| Jun 30, 2024 | 63,045.00 |
| Jun 30, 2024 | 63,045.00 |
| Mar 31, 2024 | 69,983.00 |
| Mar 31, 2024 | 69,983.00 |
| Dec 31, 2023 | 91,410.00 |
| Dec 31, 2023 | 91,410.00 |